-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on RXO, Lowers Price Target to $15

Benzinga·01/08/2026 20:13:50
Listen to the news
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $16 to $15.